| ncRNA name | hsa-miR-24 |
| ncRNA Category | miRNA |
| Disease name | retinoblastoma (RB) |
| Species | Homo sapiens |
| Tissues/Cell_line | RB cell line Y79; RPE cell line ARPE-19 |
| Methods | qRT-PCR, transfection, CCK-8 assay, transwell assay, luciferase reporter assay, Western blot |
| Expression pattern | down-regulated |
| Functional description | ANRIL negatively regulated the expression of miR-24, which played tumor suppressive roles in retinoblastoma cells. ANRIL positively regulated the expression of c-Myc, which was a target gene of miR-24 in retinoblastoma cells. |
| PubMed ID | 30703428 |
| Year | 2019 |
| Title | ANRIL acts as onco-lncRNA by regulation of microRNA-24/c-Myc, MEK/ERK and Wnt/β-catenin pathway in retinoblastoma. |
| Drug-related ncRNA | NO |
Copyright © Institution of Biomedical Big Data, Wenzhou Medical University All rights reserved.